The mutational profile of our patients was enriched in alterations involving well-known drivers in MM, such as KRAS (17.5%), NRAS (12.3%), DIS3 (15.8%) or FAM46C (7%) (Table 1). Here, NRAS is linked to Miyoshi myopathy.